Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying blaOXA-48

ABSTRACT Ledaborbactam is a novel boronic-acid inhibitor of class A, C, and D β-lactamases, including OXA-48, being developed in combination with ceftibuten. Herein, we examined the in vitro activity of this combination vs. other orally bioavailable compounds against 50 Enterobacterales-carrying bla...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Maria F. Mojica, Elise T. Zeiser, Scott A. Becka, David A. Six, Greg Moeck, Robert A. Bonomo, Krisztina M. Papp-Wallace
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology 2026-02-01
סדרה:	Microbiology Spectrum
נושאים:	β-lactamases Enterobacterales β-lactam OXA-48 carbapenemase β-lactamase inhibitor
גישה מקוונת:	https://journals.asm.org/doi/10.1128/spectrum.03148-25
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!